Biomarker measurements from single time points are often used to make inferences about longer periods of toxicant intake. However, toxicant exposures rarely, if ever, occur under steady-state conditions, and biomarkers are typically most sensitive to recent toxicant exposures. Moreover, toxicant exposures are typically episodic and vary in magnitude over time. While it is often believed that the error introduced by the steady-state assumption is minimal and can safely be ignored, no rationale is typically presented to support this belief. Moreover, no guidelines have been established for determining a de minimus error level or for estimating the degree of error potentially introduced by a fallacious steady-state assumption in biomarker interpretation. We present a statistical framework for evaluating the potential magnitude of the error introduced by the steady-state fallacy and demonstrate applications of the framework to blood mercury and hair mercury exposure biomarkers in human adults. The magnitude of error clearly depends on many factors, including the exposure frequency, exposure magnitude, exposure duration, and exposure inference duration. Graphical presentation of the error as a function of those factors provides insight into the interpretation of mercury exposure biomarkers. We describe a general approach for determining the mean and variance of temporal error, present explicit solutions for several special cases, and demonstrate an example using the framework to evaluate the error resulting from the use of a steady-state model to estimate time-varying exposure from mercury biomarkers.
Introduction
Biomarker measurements such as hair mercury concentrations and blood lead concentrations are commonly used in environmental health risk assessment as indicators of toxicant exposure. Health risks assessments, epidemiologic studies, cleanup and emissions goals, and other assessments and policies are determined based in part on these measurements (US Environmental Protection Agency (EPA), 1996 (EPA), , 2001 Ponce et al., 1998) . In these assessments, biomarker measurements from single time points are often used to make inferences about longer periods of toxicant intake. For example, blood mercury concentrations are typically assumed to reflect steady-state conditions, in which the mercury input rate to the blood equals the mercury output rate and the blood mercury concentration is stable over time. These mercury exposure rates are typically estimated by multiplying blood mercury concentrations by a steady-state ratio (World Health Organization (WHO), 1990; EPA, 2001) . Recognizing that mercury steady-state ratios likely vary among individuals, researchers have recently demonstrated several methods for estimating the extent of this variability, and suggested results for application in exposure and risk assessment (Lipfert et al., 1996; Carrington et al., 1997; Stern, 1997; Ponce et al., 1998) .
However, mercury exposures are not likely to occur under steady-state conditions. Steady-state conditions require stable biokinetics, a constant rate of exposure, dynamic equilibrium among body tissues, and a sufficiently long exposure period for mercury concentrations to stabilize in all relevant tissues. Several features of mercury exposures are likely to violate these assumptions. Normal growth and other biokinetic changes occur during pregnancy, maturation, and aging. Most mercury exposures are occupational or dietary, both of which occur intermittently and episodically, rather than at a constant rate. In addition, these exposure events probably vary in magnitude, and may have underlying temporal patterns such as seasonal consumption of mercury contaminated fish. Even if the frequency and magnitude of mercury exposure events are constant, the specific time course of exposure events may be affected by stochastic variation. For example, an individual might eat on average one fish meal per week and ingest 10 mg of mercury for each fish meal, but each week the meal might fall on a different day, or multiple fish meals may be eaten during some weeks and no fish meals during others. Any variation affects the pattern of mercury retention in the body, rendering the steady-state assumption invalid. The potential effects of this steady-state fallacy are generally assumed to be negligible, but have not been thoroughly examined for mercury or other toxicants.
Similar issues apply to other contaminant exposures. Childhood lead exposure in the US, for example, is thought to occur primarily through paint, dust, and soil ingestion (Agency for Toxic Substances and Disease Registry (ATSDR), 1993). These activities are episodic in nature and seem to occur sporadically and at varying rates (Wong et al., 2000) . Existing risk assessment models, however, typically treat soil and dust ingestion as continuous processes with constant or piecewise constant rates (EPA, 1990; 1994) . As a result, observed population variability in blood lead levels is typically attributed to exposure rate differences and measurement errors solely, despite likely contributions from temporal exposure variation and childhood biokinetic changes.
Environmental health models often implicitly or explicitly assume steady-state or continuous exposure conditions. Whether or not these temporal fallacies are quantitatively important has not been thoroughly addressed. Sherlock and Quinn (1988) illustrated through simulation that the potential impact of varying the timing of infrequent exposure events could substantially impact blood mercury concentrations predicted by a standard mercury biokinetic model. In a similar simulation with the same biokinetic model, we demonstrated a substantial temporal impact from varying exposure magnitudes over time (Bartell et al., 2000) . While simulation can be used to investigate the temporal biomarker variability associated with a specific exposure history in a particular biokinetic model, it is difficult to determine the conditions under which variability is large using simulation alone. Slob (1993) presented a survey-based approach to estimating dietary exposure variability in a given population and discussed its potential application to dose estimation, but this approach is limited to the assessment of populations in which extensive survey information has already been collected. Several authors have tackled the issue of longterm exposure estimation using short-term survey information (Wallace et al., 1994; Buck et al., 1995) , but these approaches do not address the use of biomarker information. Although it is tempting to treat biomarkers as surrogate exposure measures with normal or lognormal error, their interpretation is more complicated due to the toxicokinetic process and the departures from normality caused by intermittent exposures. General methods for evaluating the impact of temporal exposure variation on biomarker-based exposure estimates would be useful for determining conditions under which fallacious steady-state assumptions introduce acceptably low error, for adjusting exposure and risk estimates, and for developing guidance on the temporal aspects of biomarker sampling.
In this paper, we propose a general framework for evaluating the expected impacts of temporal exposure intermittency and variation on biomarker sample variability.
We define ''temporal error'' as the difference between the actual average exposure in a given time period and the exposure inferred from a single biomarker sample and steady-state assumption, develop general equations describing some of the statistical properties of this error measure, and apply this framework to mercury blood and hair biomarkers.
Methods

General Model to Quantify Temporal Error
We establish a general model for expressing the relationship of longitudinal intermittent exposure data and resulting biomarker measurements. ''Exposure'' is defined broadly as the intake of a compound (e.g. a nutrient, chemical contaminant, or radionuclide) into the body. The exposure magnitude and spacing strongly influence the error resulting from a fallacious steady-state assumption, but these conditions are not typically measured frequently in real applications. We therefore represent them with random variables and develop explicit formulas for the expectation and variance of temporal error based on the properties of the exposure variables.
Biomarker measurements such as blood mercury concentrations are often used in environmental health risk assessment to estimate exposure rates for specific toxicants. For example, a common technique is to retrospectively estimate the mean toxicant intake rate ðÎ IÞ from a single blood toxicant measurement (M t ) on day t:
where b is an estimate of the steady-state ratio of the biomarker, concentration to the exposure rate. For mercury exposure and the blood mercury biomarker this steady-state model is typically used with values of b near 0.95 ppm mg
À1
day (WHO, 1990) . This expression forÎ I assumes that the intake rate is constant for a long enough period of time for the biomarker concentration to reach equilibrium. Other exposure assessments rely on models based on dietary studies and/or environmental measurements. Ideally, a complete continuous exposure time profile would be determined for every individual. More commonly, exposures are characterized using a discrete model, so that an exposure history might be written as a series of values I 1 ; I 2 ; . . . ; I t , where each value I i represents the total toxicant intake during time period i. Either model might be expressed as a function of exposure occurrence and exposure magnitude. For example, a daily exposure model allows each day's intake to be characterized with an occurrence indicator (A i ) and an exposure magnitude (X i ):
A i takes the value of 1 if there is any exposure on day i, or 0 if there is no exposure on day i. While I i could also be expressed
Temporal error using biomarkers Bartell et al. as a single variable, this form is more convenient for describing intermittent exposures. For example, A A describes the observed frequency of exposure events and X i could represent a random sample from a distribution of potential exposure magnitudes. In the discrete exposure model, the average intake rate ð I IÞ during days t 0 to t is calculated as I I ¼ X t i¼maxðt 0 ;1Þ
where t 0 is allowed to take on a negative values but t is restricted to positive integers not less than t 0 . The form of this equation allows for the evaluation of situations in which the exact exposure duration is unknown, for example, estimating the average exposure for 365 days although exposure has only occurred for 340 days. Most chemicals move among many bodily tissues after being ingested or otherwise introduced. Mercury, for example, is distributed to the blood, brain, liver, kidney and other organs, and is excreted primarily through the urine, feces, and hair (Gray et al., 1995) . A variety of complex toxicokinetic models have been proposed for these processes in humans. We propose the following general discrete model for the concentration of compound (either in the original form or as a metabolite) on day t in human tissues:
where each w i,t is a fixed weight reflecting the dilution and retention of intake from day i by the sampled body tissue on day t. This model assumes that there are no exposures prior to day 1. The weights w i,t can be estimated using any particular biokinetic model which incorporates the tissue and compound of interest; it is assumed that each w i,t has a fixed value for each individual. Equation (4) is a reasonable model for blood mercury and hair mercury measurements, but it may not be reasonable for other tissues or for all toxicants. The steady-state fallacy described earlier assumes that I I ¼ I I for days t 0 through t. We describe the magnitude of error associated with the use of Eq. (1) as
Combining Eqs. (1)- (5), the following expression can be written:
where
General expressions for the expected value and variance of temporal error follow:
and
Under special conditions, these formulas simplify to more convenient expressions. For example, if A i , X i are independent of each other and themselves across all values of i, we denote the temporal error as . D and write the expressions as
If in addition to the independence condition, A i are identically distributed and X i are identically distributed for all values of i, we denote the temporal error as € D D and the following statements hold:
These expressions allow for the examination of the potential impact of steady-state fallacy on biomarker-based inferences about exposure rates. In some cases, such as autocorrelated exposure occurrences/magnitudes, explicit expressions are more complex and will not be as convenient. For example, one could use a first-order autoregressive model for identically distributed exposure magnitudes, specifying that cov 
Note that when a ¼ b ¼ 0, there is no autocorrelation and Eq. (13) reduces to Eq. (10).
Exposure Inference from Blood and Hair Mercury Biomarkers using a Simple Biokinetic Model
For adult humans, contininous time single-compartment models are sometimes used to represent contaminant biokinetics after a period of dietary exposure. For intermittent exposures to compounds with slow elimination rates such as mercury, it is reasonable to approximate the continuous model using discrete time intervals 1 day in length (Sherlock et al., 1984) . The blood concentration M t on day t can then be written as a sum of exponentially weighted intakes:
where f is the fraction of mercury intake that equilibrates into blood (including any losses from incomplete absorption), v blood is the volume of blood, I i is the mercury intake on day i, and k is a positive first-order elimination rate constant. Note that this is equivalent to Eq. (4) with w i;t ¼ ðf =v blood Þe ÀkðtÀiÞ for irt. The steady-state mercury blood to exposure ratio can also be written in terms of kinetic parameters as
In Figure 1 , we illustrate the behavior of w i,t assuming nominal values of 0.0475 for f, 5 l for v blood , and 0.014 day
À1
for k (Stern, 1997; EPA, 2001) . The values of w i,t increase exponentially as i approaches t, indicating that the most recent exposures have the strongest influence on any given blood measurement. Under the earlier assumption that A i are independent and identically distributed (i.i.d.) and X i are i.i.d., the expressions for w i,t and b can be substituted into Eqs. (11) and (12). The resulting expressions for the mean and variance of temporal error for the blood biomarker include several geometric series and can be simplified to
The terms e -k and e -2k in the above expressions can be written more elaborately as e
Àkp and e À2kp where p ¼ 1 day, the discretization period. As p ¼ 1 there is no need to retain p in the equations. Hair mercury measurements are another common exposure biomarker (WHO, 1990) . The growing hair concentration and blood concentration are typically assumed to be in equilibrium with a concentration ratio of about 250, implying that a strand of hair contains a continuous record of 250 times the instantaneous blood concentration throughout the period of time the strand was grown. Hair is typically analyzed for mercury in one large strand or several sequential segments, each of which reflects the average blood concentration during the period of segment growth. If t 1 and t are first and last days of hair growth contained by a hair segment and h is the hair:blood equilibrium ratio for mercury, the following expression can be derived:
Equation (18) indicates that for segmental hair analysis, the exposure days with the greatest influence on the biomarker measurement are those that lie nearest to t 1 . To either side of t 1 the values of w i,t decrease rapidly. For example, for nominal values of 250 for h and 30, 90, and 180 days for t-t 1 +1, values of w i,t are displayed in Figure 1 . Under i.i.d. conditions, the mercury intake at and near the time of growth for the oldest tip of the hair segment is most influential on the segment's mercury concentration. The steady-state mercury hair to exposure ratio can be expressed as
In order to evaluate the temporal error properties for hair biomarkers, Eqs. (18) and (19) are combined with Eqs. (11) and (12) Temporal error using biomarkers Bartell et al.
Results
We evaluate the mean and variance of temporal error for the hair mercury biomarkers using the i.i.d. model and a 30-day exposure inference window. As shown in Figure 2 , the mean error or bias associated with the steady-state fallacy is a small fraction of average daily intake for large values of t (greater than about 250 days). As exposure duration decreases and the hair segment length increases, the magnitude of relative bias generally increases in the negative direction, indicating an underestimate of average exposure. Interestingly, the relative bias begins to increase for exposure durations shorter than the 30-day exposure inference period and may even exceed zero, indicating an overestimate of average exposure. In other words, biomarker-based exposure inference in this model is expected to underestimate the average exposure rate if insufficient time has lapsed between the beginning of exposure and biomarker sampling, given that the exposure duration is longer than the exposure inference window. We also observe that the mean temporal error is close to zero if the exposure history is long enough and the biomarker is randomly sampled with respect to any particular exposure event.
While these principles for bias are generally understood, the variance of € D D is not typically considered. Figure 3 indicates the effects of exposure duration and hair segment length on relative temporal error variance for a 30-day exposure inference window. The variance appears to increase with both exposure duration and with hair segment length, but appears to level out at around 3.3% of the daily intake variance.
The temporal error equations for the hair mercury biomarker reduce to those shown for the blood biomarker when t 1 ¼ t; thus Figures 2 and 3 also reveal the properties of the blood mercury biomarker in addition to hair mercury.
The variance in daily intake has a strong impact on the mean and variance of the temporal error. For example, for A and X independent, EA ¼ 0.2 day
À1
, EX ¼ 10 mg, and Var X ¼ 5 mg 2 , the mean and variance in daily intake are 2 mg 1 day À1 and 17 mg 2 day
À2
. Suppose that exposures have been occurring for 500 days, roughly 10 times the biological half-life of mercury in the blood. A single blood measurement is taken and used to estimate the average mercury exposure rate over the last 30 days, using a steady-state model. Using Eqs. (16) and (17), we find that the expected value and variance for the temporal error are 0.012 mg day À1 and 0.296 mg 2 day À2 , respectively. In this example, assuming that the temporal error has an approximately normal distribution, an approximate 95% confidence interval for the temporal error is (À1.06, 1.08 mg day À1 ) compared to the mean exposure rate of 2 mg day
À1
. This interval is larger than that one might expect for such a moderate variance in X; moreover, the exact error distribution is likely to be skewed due to the intermittent exposures, resulting in an even larger exact confidence interval. In fact, the ''worst case'' 95% confidence interval given by the Chebyshev inequality (DeGroot, 1989) is as wide as (À2.42, 2.44 mg day
). This example illustrates that a long history of exposure is not sufficient reason to ignore the effects of variable exposure magnitudes and intermittent exposures when making individual exposure inferences using biomarkers. More careful attention is warranted.
Considering the same example with first-order autocorrelation among exposure indicators and the first-order autocorrelation among exposure magnitudes is also possible using Eq.(13). For b ¼ 0.8, strongly autocorrelated exposure magnitudes, the temporal error variance increases only slightly to 0.318 mg 2 day À2 . For b ¼ À0.8, the variance is 0.293 mg 2 day
À2
, only slightly lower than that in the original example. In contrast, for a ¼ 0.8, strongly autocorrelated exposure indicators, the temporal error variance swells to 2.06 mg 2 day À2 , indicating a much larger impact of the steady-state fallacy than for the case of independent exposure indicators. This situation describes dietary mercury exposures that are typically clustered in time, such as fish consumption for several days in a row and many days between consumption periods. Negative autocorrelation among exposure indicators describes a pattern of spaced exposures, such as that found for a person who prefers not to eat fish 2 days in a row.
Extending the example described above (without autocorrelation) to hair mercury content for a variety of exposure frequencies, Figure 4 shows the ''coefficient of variation'' or standard deviation of the temporal error as a fraction of the expected daily intake. The coefficient of variation increases rapidly as exposure frequency decreases. For example, at an exposure frequency of 0.1 day À1 and a hair segment corresponding to one day's growth, the coefficient of variation for the temporal error is 41%. The coefficient of variation also increases moderately with the hair segment length. Intermittency of exposure contributes substantially to temporal variability even at high exposure frequencies.
Discussion
Blood mercury biomarkers appear to be superior for reflecting the most recent exposures in that they reduce the potential for bias under assumed i.i.d. conditions. Hair mercury may be superior for measuring longer term or historic exposures from the perspective of mitigating bias, but longer hair segments may lose precision due to increased temporal error variance, particularly when the goal is estimating relatively short-term exposures such as those for the last 30 days. In any application of biomarkers to individual exposure inference, great caution is warranted due to the potential for temporal error induced by the steadystate fallacy. Our results suggest that individual exposure inferences may be extremely sensitive to small departures from steady-state including variable exposure magnitudes and intermittent exposures. The exposure frequency and degree of autocorrelation among exposure events seem to have particularly strong influences on the temporal error variance; that is, the timing of exposure events is critical in determining the reliability of biomarker-based exposure estimates. The bias associated with the steady-state fallacy is not affected by the length of the exposure inference window provided that the window is shorter than the exposure duration. However, the variance of temporal error changes substantially with the length of the exposure inference window. Exposure inference windows larger than 30 days are not specifically addressed in this manuscript but can be examined using our model.
There are several important limitations to our approach. We assume that simple linear toxicokinetics hold for mercury, although recent toxicokinetic models for mercury typically include multiple compartments and other potential departures from our model (Clewell et al., 1999) . It is unlikely that fine adjustment of our approach using a more detailed toxicokinetic model would substantially alter our conclusions, but we have not yet investigated this possibility. We also assume that the kinetic parameters f, h, k, and v blood are all known. In fact, several of these parameters are not easily measured and appear to vary from individual to individual. For example, as one reviewer of this manuscript noted, published estimates of the hair:blood equilibrium ratio for mercury vary from 140 to 370. We assume that the growth period for a hair strand is readily obtainable, although there is some evidence suggesting that hair growth rates are unstable and widely variable even within a single individual. The population variability and measurement uncertainty associated with these parameters add complexity to this problem and is not captured in this model which is directed solely at determining the magnitude of temporal error. Future work may include an expansion of the model framework to evaluate the overall impacts of other uncertainties along with the steady-state fallacy. Statistical methods for biomarker-based exposure inference in populations are also under development.
The formulas and results discussed here are applicable to any one compartment biokinetic model with first-order elimination of the compound of interest, so long as the initial conditions and other characteristics match those presented here and appropriate kinetic parameters are chosen. Although the general approach was developed with blood and hair mercury measurements in mind, it is potentially applicable to many other biomarkers. Nutritional biomarkers, for example, might be examined using these methods. In some case, such as for solvent exposure, toxicokinetics are rapid and 1 day is too long for discrete treatment. The length of the discrete exposure period should be chosen to be substantially smaller than the half-life of the Temporal error using biomarkers Bartell et al. compound in order for the discrete approximation to be accurate.
The approach used here is not limited to exposure biomarkers. If w i,t is viewed more broadly as an ''influence weight'' rather than a dilution/retention factor, the approach could also be applied to certain biomarkers of effect. It has been suggested that exponential decay curves could reasonably represent a wide variety of toxicodynamic processes (Rhomberg, 1999) , at least at first approximation. Future work may include the application of this model in a toxicodynamic setting.
